Our Mission is Providing Superior Solutions
TheraCom is the leading provider of pre- and post-commercialization support services to the biopharmaceutical, device, diagnostic and vaccine manufacturing communities. Our mission is to provide superior solutions that will assure successful product commercialization, minimizing time to peak sales performance.
Our goal is to serve patient communities and their unique needs by providing responsive, quality care. Offering the highest levels of service to patients, physicians, specialty pharmacies, product distributors and other care providers, TheraCom seeks to remove barriers to access and drive positive therapeutic outcomes.
A History of Successful Product Commercialization
Founded in 1996, TheraCom was among the first to provide specialty commercialization services on behalf of the manufacturer and remains uniquely positioned as a provider to the biotechnology and pharmaceutical community today.
In 2011, TheraCom was acquired by AmerisourceBergen Corporation, joining Lash Group as part of AmerisourceBergen Consulting Services (ABCS). Together, Lash Group and TheraCom offer an extensive platform of services and solutions to support the growing demand for patient access and reimbursement services, and support the need for unique distribution solutions.
TheraCom works on behalf of the manufacturer, often as an extension of the manufacturer's brand, to deliver services that will lead to successful product uptake and support the ultimate dispensing or distribution of the product on a patient-by-patient basis.